Volume 7, Issue 3 (Autumn 2003)                   2003, 7(3): 23-28 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Kamyabi, Zamiri Z, Ramezani A. Effect of pethidine on the duration of stages of labour. Journal of Inflammatory Diseases. 2003; 7 (3) :23-28
URL: http://journal.qums.ac.ir/article-1-223-en.html
Abstract:   (12176 Views)
Background: Shorter labour not only prevents unpleasent memory of delivery but also decreases the probability of uterine atony, post partum hemorrhage and purperal infection. Objective: The aim of this study was to determine the effect of intramuscular pethidine on the duration of stage 1,2 and 3 of labour. Methods: In this clinical trial study, 88 primiparous women with term pregnancy were observed. In all of the cases, labour pains started spontaneously and had fetal and maternal indication for normal vaginal delivery. They were divided into two groups randomly. The first group recieved 75mg IM pethidine and the second group received the same volume of normal saline. Injection was done when cervical dilatation reached to 5cm (at the begining time of active phase of labour). Findings: The duration from drug administration until 10cm cervical dilatation, and also until fetus and placental expulsion were shorter in pethidine group and there were statistically significant difference between two groups (P<0.0001). There was no significant statistical difference between duration and interval of uterine contractions before and after drug administration (P>0.05). Conclusion: Pethidine in an appropriate dosage is an effective drug in decreasing the length of stage 1,2 and 3 of labour, and has no effect on uterus contractions.
Full-Text [PDF 236 kb]   (6251 Downloads)    
Type of Study: Research | Subject: Obsterics & Gynecology

Add your comments about this article : Your username or Email:

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2022 CC BY-NC 4.0 | Journal of Inflammatory Diseases

Designed & Developed by : Yektaweb